Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells
Filip Bergqvist(Karolinska University Hospital), Per‐Johan Jakobsson(Karolinska University Hospital), Petter Englund(Stockholm University), Elena Ossipova(Karolinska University Hospital), Helena Idborg(Karolinska University Hospital), Antonio Checa(Karolinska Institutet), Payam Emami Khoonsari(Stockholm University), Kim Kultima(Uppsala University), Craig E. Wheelock(Karolinska University Hospital), Joan Raouf(Karolinska University Hospital), Marina Korotkova(Karolinska University Hospital), Karin Larsson(KTH Royal Institute of Technology), Karin Englund(Stockholm University)
Cited by 24
Related Papers
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines
|Journal of Lipid Research|2018|325
Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
|European Respiratory Journal|2013|270
Faced with inequality: chicken do not have a general dosage compensation of sex-linked genes
|BMC Biology|2007|257
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
|Frontiers in Pharmacology|2022|187